The Omega-3 Fatty Acid Docosahexaenoic Acid Modulates Inflammatory Mediator Release in Human Alveolar Cells Exposed to Bronchoalveolar Lavage Fluid of ARDS Patients
Open Access
- 2 August 2015
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2015, 1-11
Abstract
Background. This study investigated whether the 1 : 2 ω-3/ω-6 ratio may reduce proinflammatory response in human alveolar cells (A549) exposed to anex vivoinflammatory stimulus (bronchoalveolar lavage fluid (BALF) of acute respiratory distress syndrome (ARDS) patients).Methods. We exposed A549 cells to the BALF collected from 12 ARDS patients. After 18 hours, fatty acids (FA) were added as docosahexaenoic acid (DHA,ω-3) and arachidonic acid (AA,ω-6) in two ratios (1 : 2 or 1 : 7). 24 hours later, in culture supernatants were evaluated cytokines (TNF-α, IL-6, IL-8, and IL-10) and prostaglandins (PGE2and PGE3) release. The FA percentage content in A549 membrane phospholipids, content of COX-2, level of PPARγ, and NF-κB binding activity were determined.Results. The 1 : 2 DHA/AA ratio reversed the baseline predominance ofω-6 overω-3 in the cell membranes (P< 0.001). The proinflammatory cytokine release was reduced by the 1 : 2 ratio (P< 0.01 to P< 0.01). The 1 : 2 ratio reduced COX-2 and PGE2(P< 0.001) as well as NF-κB translocation into the nucleus (P< 0.01), while it increased activation of PPARγand IL-10 release (P< 0.001).Conclusion. This study demonstrated that shifting the FA supply fromω-6 toω-3 decreased proinflammatory mediator release in human alveolar cells exposed to BALF of ARDS patients.Keywords
This publication has 62 references indexed in Scilit:
- Experimental Evidence of-3 Polyunsaturated Fatty Acid Modulation of Inflammatory Cytokines and Bioactive Lipid Mediators: Their Potential Role in Inflammatory, Neurodegenerative, and Neoplastic DiseasesBioMed Research International, 2013
- A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury*Critical Care Medicine, 2011
- Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injuryIndian Journal of Critical Care Medicine, 2011
- Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trialCritical Care, 2010
- Decreased Polyunsaturated Fatty Acid Content Contributes to Increased Survival in Human Colon CancerJournal of Oncology, 2009
- Acute Lung Injury Is Reduced in fat-1 Mice Endogenously Synthesizing n-3 Fatty AcidsAmerican Journal of Respiratory and Critical Care Medicine, 2009
- [Retracted] A Role for PPAR γ in the Regulation of Cytokines in Immune Cells and CancerPPAR Research, 2008
- Acute respiratory distress syndromeBMJ, 2007
- Arachidonic and docosahexaenoic acids reduce the growth of A549 human lung-tumor cells increasing lipid peroxidation and PPARsChemico-Biological Interactions, 2007
- Nutritional Support in Acute Lung Injury and Acute Respiratory Distress SyndromeNutrition in Clinical Practice, 2001